Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
Lundbeck stays positive on Rexulti PTSD use despite adcomm vote
There’s a high medical need in PTSD as the last FDA approval in the field was 23 years ago, Lundbeck's R&D chief noted on an investor call.
Angus Liu
Aug 15, 2025 10:50am
The battle of the obesity drug heavyweights
Aug 15, 2025 9:14am
Sana drops Washington plant build-out, pivots to CDMOs
Aug 14, 2025 9:20am
Summit skips quarterly investor call as deal rumors swirl
Aug 12, 2025 10:29am
Lilly CEO David Ricks hits back against MFN drug pricing reform
Aug 7, 2025 11:04am
With $1B in debts due in 2027, Sarepta weighs efficiency measures
Aug 6, 2025 5:44pm
